Lower trial participation by culturally and linguistically diverse (CALD) cancer patients is largely due to language barriers

ConclusionsLimited English proficiency seems particularly unfavorable to trial participation. Development and evaluation of strategies to overcome language barriers (e.g. simplified and translated multimedia participant information materials) is needed.

Source: Asia-Pacific Journal of Clinical Oncology - October 30, 2017 Category: Cancer & Oncology Authors: Allan ‘Ben’ Smith, Meera Agar, Geoff Delaney, Joseph Descallar, Kelsey Dobell‐Brown, Melissa Grand, Jennifer Aung, Pinky Patel, Nasreen Kaadan, Afaf Girgis Tags: ORIGINAL ARTICLE Source Type: research